glp-1 agonist history Receptor Market Size Timeline of GLP-1 discovery and
Description
Studies in mice and humans showed that GLP-1 liraglutide acts directly and indirectly in LDL and VLDL catabolism, increases lipoprotein lipase gene expression responsible for TAG hydrolysis, and reduces apolipoprotein B48, diacylglycerol O -acyltransferase 1, and microsomal transfer protein gene expression, all of which are involved in chylomicron synthesis [77, 78]

Due to its potential in preserving lean mass and promoting high-quality weight loss, bimagrumab could be an attractive treatment option for obesity with muscle wasting

[DOI] [PMC free article] [PubMed] [Google Scholar] 70.Davies MJ, Bergenstal R, Bode B, et al

doi.org/10.1016/j.psyneuen.2025.107415

Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al

Diabetes Care 34(Supplement_2):S279-84 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
